Home LiteratureArticle Details
PMID: 2370677 Published · ppublish English Journal Article Research Support, U.S. Gov't, P.H.S.

Differences in the basal activity of the long terminal repeat determine different replicative capacities of two closely related human immunodeficiency virus type 1 isolates.

Journal of virology ·Vol. 64 ·No. 8 ·1990-08-00 ·Pages 3654-60

Golub EI, Li GG, Volsky DJ

Abstract

Two human immunodeficiency virus type 1 (HIV-1) variants derived from a single parental isolate were found to differ substantially in their ability to replicate in CD4-positive cells. Using transient chloramphenicol acetyltransferase expression assays, we show that the long terminal repeat (LTR) of the better-replicating virus has significantly higher capacity than that of the companion virus to direct gene expression in T cells. Sequence data and site-specific mutagenesis experiments demonstrate that the higher LTR activity of the better-replicating HIV-1 is due to a combined effect of two mutations: (i) a point mutation in position -94 (relative to the transcriptional start site), which is located between the two subunits of the HIV-1 enhancer, and (ii) a duplication of 24 base pairs in positions -128 to -151, which was not previously known to be involved in any regulatory function. The presence of these mutations increases the basal level of the LTR-driven gene expression and does not influence the degree of induction caused by the viral tat gene product or by cell activation. Reciprocal exchange of LTRs between the respective viral DNAs results in a change of a recombinant virus replication pattern consistent with the activity of the particular LTR. These experiments suggest that the HIV-1 LTR is one of the sites which determines the functional heterogeneity of HIV-1.

MeSH Terms
Base Sequence CD4 Antigens/analysis Cell Line Chloramphenicol O-Acetyltransferase/genetics Cloning, Molecular DNA, Viral/genetics Genetic Variation HIV-1/genetics,isolation & purification,physiology Humans Molecular Sequence Data Mutation Recombination, Genetic Repetitive Sequences, Nucleic Acid Restriction Mapping T-Lymphocytes Transcription, Genetic Transfection Virus Replication
Chemicals
CD4 Antigens DNA, Viral Chloramphenicol O-Acetyltransferase
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Golub E I
Molecular Virology Laboratory, St. Luke's/Roosevelt Hospital Center, New York, New York.
Li G G
Volsky D J
References (38)
38 references, click to expand
  1. Interactions of cellular proteins involved in the transcriptional regulation of the human immunodeficiency virus.
    EMBO J. 1987 Dec 1;6(12):3761-70 PMID: 3428273
  2. Phorbol ester enhances human immunodeficiency virus-promoted gene expression and acts on a repeated 10-base-pair functional enhancer element.
    Mol Cell Biol. 1987 Oct;7(10):3759-66 PMID: 3500398
  3. Biologic features of HIV-1 that correlate with virulence in the host.
    Science. 1988 Apr 1;240(4848):80-2 PMID: 2832945
  4. Differential syncytium-inducing capacity of human immunodeficiency virus isolates: frequent detection of syncytium-inducing isolates in patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related complex.
    J Virol. 1988 Jun;62(6):2026-32 PMID: 3130494
  5. Identification and purification of a human immunoglobulin-enhancer-binding protein (NF-kappa B) that activates transcription from a human immunodeficiency virus type 1 promoter in vitro.
    Proc Natl Acad Sci U S A. 1988 Jul;85(13):4700-4 PMID: 3133660
  6. Type-restricted neutralization of molecular clones of human immunodeficiency virus.
    Science. 1988 Jul 15;241(4863):357-9 PMID: 3388046
  7. Purification of the human immunodeficiency virus type 1 enhancer and TAR binding proteins EBP-1 and UBP-1.
    EMBO J. 1988 Jul;7(7):2117-30 PMID: 3138113
  8. Cytokines alter production of HIV-1 from primary mononuclear phagocytes.
    Science. 1988 Sep 23;241(4873):1673-5 PMID: 3047875
  9. Low-cytopathic infectious clone of human immunodeficiency virus type I (HIV-I).
    FEBS Lett. 1988 Oct 10;238(2):257-61 PMID: 2458968
  10. Differences in cytopathogenicity and host cell range among infectious molecular clones of human immunodeficiency virus type 1 simultaneously isolated from an individual.
    J Virol. 1988 Nov;62(11):4078-85 PMID: 3172338
  11. Fidelity of HIV-1 reverse transcriptase.
    Science. 1988 Nov 25;242(4882):1168-71 PMID: 2460924
  12. Repeated B motifs in the human immunodeficiency virus type I long terminal repeat enhancer region do not exhibit cooperative factor binding.
    Proc Natl Acad Sci U S A. 1988 Dec;85(24):9406-10 PMID: 3200827
  13. Interaction of a noncytopathic human immunodeficiency virus type 1 (HIV-1) with target cells: efficient virus entry followed by delayed expression of its RNA and protein.
    Virology. 1990 May;176(1):184-94 PMID: 2184575
  14. CONTINUOUS CULTURE OF HUMAN LYMPHOBLASTS FROM PERIPHERAL BLOOD OF A CHILD WITH ACUTE LEUKEMIA.
    Cancer. 1965 Apr;18:522-9 PMID: 14278051
  15. Alterations in binding characteristics of the human immunodeficiency virus enhancer factor.
    J Virol. 1988 Jan;62(1):218-25 PMID: 3257103
  16. DNA sequencing with chain-terminating inhibitors.
    Proc Natl Acad Sci U S A. 1977 Dec;74(12):5463-7 PMID: 271968
  17. Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS).
    Science. 1983 May 20;220(4599):868-71 PMID: 6189183
  18. Frequent detection and isolation of cytopathic retroviruses (HTLV-III) from patients with AIDS and at risk for AIDS.
    Science. 1984 May 4;224(4648):500-3 PMID: 6200936
  19. Construction of recombinants between molecular clones of murine retrovirus MCF 247 and Akv: determinant of an in vitro host range property that maps in the long terminal repeat.
    J Virol. 1985 Jan;53(1):152-7 PMID: 2981334
  20. Trans-acting transcriptional regulation of human T-cell leukemia virus type III long terminal repeat.
    Science. 1985 Jan 11;227(4683):171-3 PMID: 2981427
  21. Rapid and efficient site-specific mutagenesis without phenotypic selection.
    Proc Natl Acad Sci U S A. 1985 Jan;82(2):488-92 PMID: 3881765
  22. The location of cis-acting regulatory sequences in the human T cell lymphotropic virus type III (HTLV-III/LAV) long terminal repeat.
    Cell. 1985 Jul;41(3):813-23 PMID: 2988790
  23. Genomic diversity of the acquired immune deficiency syndrome virus HTLV-III: different viruses exhibit greatest divergence in their envelope genes.
    Proc Natl Acad Sci U S A. 1985 Jul;82(14):4813-7 PMID: 2991896
  24. Human T-lymphotropic retroviruses.
    Nature. 1985 Oct 3-9;317(6036):395-403 PMID: 2413364
  25. Retrovirus-induced spongiform encephalopathy: the 3'-end long terminal repeat-containing viral sequences influence the incidence of the disease and the specificity of the neurological syndrome.
    Proc Natl Acad Sci U S A. 1985 Dec;82(24):8818-22 PMID: 3866255
  26. Activation of the AIDS retrovirus promoter by the cellular transcription factor, Sp1.
    Science. 1986 May 9;232(4751):755-9 PMID: 3008338
  27. AIDS retrovirus (ARV-2) clone replicates in transfected human and animal fibroblasts.
    Science. 1986 May 23;232(4753):998-1001 PMID: 3010461
  28. Identification and characterization of conserved and variable regions in the envelope gene of HTLV-III/LAV, the retrovirus of AIDS.
    Cell. 1986 Jun 6;45(5):637-48 PMID: 2423250
  29. Genetic variation in HTLV-III/LAV over time in patients with AIDS or at risk for AIDS.
    Science. 1986 Jun 20;232(4757):1548-53 PMID: 3012778
  30. Genetic variability of the AIDS virus: nucleotide sequence analysis of two isolates from African patients.
    Cell. 1986 Jul 4;46(1):63-74 PMID: 2424612
  31. Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone.
    J Virol. 1986 Aug;59(2):284-91 PMID: 3016298
  32. Replicative capacity of human immunodeficiency virus from patients with varying severity of HIV infection.
    Lancet. 1986 Sep 20;2(8508):660-2 PMID: 2429124
  33. A human T-cell line resistant to cytopathic effects of the human immunodeficiency virus (HIV).
    Virology. 1987 Jan;156(1):40-9 PMID: 3492810
  34. Mutational analysis of the human immunodeficiency virus: the orf-B region down-regulates virus replication.
    Proc Natl Acad Sci U S A. 1987 Mar;84(5):1434-8 PMID: 2434956
  35. An inducible transcription factor activates expression of human immunodeficiency virus in T cells.
    Nature. 1987 Apr 16-22;326(6114):711-3 PMID: 3031512
  36. Differential ability of human immunodeficiency virus isolates to productively infect human cells.
    J Immunol. 1987 May 15;138(10):3415-8 PMID: 3106482
  37. Cytokine-induced expression of HIV-1 in a chronically infected promonocyte cell line.
    Science. 1987 Nov 6;238(4828):800-2 PMID: 3313729
  38. Alternative mechanisms for activation of human immunodeficiency virus enhancer in T cells.
    Science. 1988 Mar 11;239(4845):1299-302 PMID: 2830675
Article Info
Journal
Journal of virology
Abbr.
J Virol
ISSN
0022-538X
Published
1990-08-00
Pages
3654-60
Language
English
Region
United States
NLM ID
0113724
PMCID
PMC249658
Subset
IM
Grants
NIAID NIH HHS · AI-25902 · United States
NIAID NIH HHS · AI-27397 · United States
NCI NIH HHS · CA37465-04 · United States
Databases
GENBANK
M64759, M64760
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com